Chronic disease rates are rising and cases are becoming more complex, with a higher share of plan members experiencing multiple co-morbidities. This growing trend necessitates an approach to chronic disease management that promotes self-management and healthy lifestyle choices, as well as helps plan members better navigate the health-care landscape, said Jeffery Chan, assistant vice-president of […]
Obesity is one of the most misunderstood diseases, with stigma and judgement contributing to the misconceptions, said Lisa Schaffer, executive director at Obesity Canada, during a session supported by Eli Lilly Canada at Benefits Canada’s 2025 Chronic Disease at Work conference. Obesity is associated with more than 200 chronic illnesses and nearly one in three […]
It took five years for Crystal Burke to put a name to the symptoms that haunted her. Heart palpitations. Insomnia so severe she slept only two to four hours a night. A newfound struggle to make decisions in her job as a nurse. Confusion when dealing with statistics, which she used to handle with ease. […]
Women over the age of 40 represent a quarter of the Canadian working population, with those between the ages of 45 and 55 the fastest growing cohort of working women. Those ages coincide with the time period when women are most likely to begin perimenopause and menopause, making it incumbent on employers to create menopause-inclusive […]
Women face unique health challenges throughout their lives — across most age groups, women experience higher rates of chronic diseases compared to men, said Neda Nasseri, pharmacist and product director of drug benefits at Desjardins Insurance, during a session supported by Pfizer Canada at Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Historically, […]
Advances in medical science and innovations in drug development necessitate updated drug plan strategies, according to Frédéric Leblanc (pictured far right), strategic leader of drug programs, group benefits and retirement solutions at iA Financial Group. During a panel discussion supported by EMD Serono Inc., GSK, iA Financial Group, Merck & Co. Inc., Novo Nordisk Canada Inc. […]
Private drug plans play a pivotal role in ensuring faster and broader access to medications for 27 million Canadians, said Joe Farago, executive director of private payers and investment at Innovative Medicines Canada, during Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. The federal government’s new pharmacare plan is designed as a universal, […]
One of the keys to managed care is to reflect on past experiences, understand lessons learned and consider their implications for the future, said Bobby Currie, director of drug evaluation at Manulife, during a session at Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. While traditional tools like caps, deductibles and co-insurance that employers […]
The Canada Pension Plan Investment Board is selling a 49 per cent stake in a portfolio of China real estate projects for nearly $235 million. The assets are part of a joint venture with Chinese real estate company Longfor Group Holdings Ltd. and are being sold to an affiliate of Dajia Insurance Group Co. Ltd. The portfolio […]
Plan sponsors are facing a chronic disease “tsunami” that is leading to higher benefits and drug plan spend and increasing disability claims. But the three root causes of this growing problem — undiagnosed health issues, the availability of primary and preventative health care and challenges navigating the health-care system — are issues plan sponsors are […]